Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
about
The Synaptic Function of α-SynucleinLysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular ToxicityAberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functionsMechanism of neuromuscular dysfunction in Krabbe disease.Astrocytes and lysosomal storage diseases.Lysosomal Storage Diseases-Regulating Neurodegeneration.Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease.Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.Substrate reduction therapy for Krabbe's disease.Perspective on innovative therapies for globoid cell leukodystrophy.Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils.Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathiesLong-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.Analysis of age-related changes in psychosine metabolism in the human brain.Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain.Is Parkinson's disease a lysosomal disorder?α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
P2860
Q27694711-4FD61964-A9DB-422E-B51C-F8004A019744Q28555118-001A9D74-F23E-4E1A-8C29-792A0C46BE9CQ34214457-1F8CAAFE-D082-4D71-88F5-5E7C7DB09C69Q35020269-DED2B6B6-B46B-42E5-BCEF-B5D329C0A404Q36332588-B91D6B00-7627-433A-86E5-3F11B14057E2Q36771137-A2998DEA-654D-4CB6-9170-4D6E70677F52Q37688803-B0A0F0D3-F346-4950-839E-275584981910Q38745885-1F02A2F5-2B9C-4FD9-99A2-30FAC80BDF87Q38957246-A2403261-D630-4AE7-BEF7-217490D52A83Q38957250-2B16E93C-5D51-414F-A4B4-9A42D553EFBAQ38957273-5E7A4A04-E98C-4F87-886A-CB6CC14953B1Q38957277-CB207778-5D17-4044-BBA1-DDF3768D45C0Q39999661-9BD5273C-509E-45D6-8852-2B589F41915CQ41122206-89C863EB-BD19-49FE-988A-EDD9218614A9Q50056656-98AE7556-85F1-4BBC-B852-C5235F894552Q51767197-AA86DFA1-F7BF-425D-AECA-42E21146230BQ55363665-EAF9DA4B-1E0E-4C2C-BD80-E2C96E4C2AD7Q58479932-70328D5A-4B64-44F1-BA23-6CFCEC0758D9Q58765487-259456B8-84D7-4E9D-A877-A12A0B234C8E
P2860
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@en
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@nl
type
label
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@en
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@nl
prefLabel
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@en
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
@nl
P2093
P2860
P50
P356
P1476
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease
@en
P2093
Aurora Lopez-Rosas
Benjamin R Smith
Ernesto R Bongarzone
Jose I Gallea
Kumiko I Claycomb
Maria I Givogri
Marta B Santos
Stephen J Crocker
P2860
P304
P356
10.1002/PATH.4328
P577
2014-02-20T00:00:00Z